• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外泌体:乳腺癌中新兴的生物标志物。

Exosome: emerging biomarker in breast cancer.

作者信息

Jia Yunlu, Chen Yongxia, Wang Qinchuan, Jayasinghe Ushani, Luo Xiao, Wei Qun, Wang Ji, Xiong Hanchu, Chen Cong, Xu Bin, Hu Wenxian, Wang Linbo, Zhao Wenhe, Zhou Jichun

机构信息

Department of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang, China.

Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, Zhejiang, China.

出版信息

Oncotarget. 2017 Jun 20;8(25):41717-41733. doi: 10.18632/oncotarget.16684.

DOI:10.18632/oncotarget.16684
PMID:28402944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5522217/
Abstract

Exosomes are nano-sized membrane vesicles released by a variety of cell types, and are thought to play important roles in intercellular communications. In breast cancer, through horizontal transfer of various bioactive molecules, such as proteins and mRNAs, exosomes are emerging as local and systemic cell-to-cell mediators of oncogenic information and play an important role on cancer progression. This review outlines the current knowledge and concepts concerning the exosomes involvement in breast cancer pathogenesis (including tumor initiation, invasion and metastasis, angiogenesis, immune system modulation and tumor microenvironment) and cancer therapy resistance. Moreover, the potential use of exosomes as promising diagnostic and therapeutic biomarkers in breast cancer are also discussed.

摘要

外泌体是由多种细胞类型释放的纳米级膜泡,被认为在细胞间通讯中发挥重要作用。在乳腺癌中,外泌体通过蛋白质和mRNA等各种生物活性分子的水平转移,正成为致癌信息的局部和全身细胞间介质,并在癌症进展中发挥重要作用。本文综述了关于外泌体参与乳腺癌发病机制(包括肿瘤发生、侵袭和转移、血管生成、免疫系统调节和肿瘤微环境)以及癌症治疗耐药性的当前知识和概念。此外,还讨论了外泌体作为乳腺癌有前景的诊断和治疗生物标志物的潜在用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af39/5522217/72215f902bd3/oncotarget-08-41717-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af39/5522217/8dc871375c70/oncotarget-08-41717-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af39/5522217/288a331d1ac3/oncotarget-08-41717-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af39/5522217/b3b5ca98aa48/oncotarget-08-41717-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af39/5522217/88b159e24b16/oncotarget-08-41717-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af39/5522217/832fd6782a81/oncotarget-08-41717-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af39/5522217/72215f902bd3/oncotarget-08-41717-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af39/5522217/8dc871375c70/oncotarget-08-41717-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af39/5522217/288a331d1ac3/oncotarget-08-41717-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af39/5522217/b3b5ca98aa48/oncotarget-08-41717-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af39/5522217/88b159e24b16/oncotarget-08-41717-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af39/5522217/832fd6782a81/oncotarget-08-41717-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af39/5522217/72215f902bd3/oncotarget-08-41717-g006.jpg

相似文献

1
Exosome: emerging biomarker in breast cancer.外泌体:乳腺癌中新兴的生物标志物。
Oncotarget. 2017 Jun 20;8(25):41717-41733. doi: 10.18632/oncotarget.16684.
2
Exosomes in development, metastasis and drug resistance of breast cancer.外泌体与乳腺癌的发生发展、转移及耐药性
Cancer Sci. 2015 Aug;106(8):959-64. doi: 10.1111/cas.12715. Epub 2015 Jul 20.
3
Tumor-derived exosomes: Potential biomarker or therapeutic target in breast cancer?肿瘤来源的外泌体:在乳腺癌中作为潜在的生物标志物或治疗靶点?
J Cell Biochem. 2018 Jun;119(6):4236-4240. doi: 10.1002/jcb.26364. Epub 2018 Mar 7.
4
Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells.转移相关蛋白 1(MTA1)通过外泌体转移,并有助于调节乳腺癌细胞中的缺氧和雌激素信号。
Cell Commun Signal. 2019 Feb 19;17(1):13. doi: 10.1186/s12964-019-0325-7.
5
Exosomal microRNA: a novel biomarker for breast cancer.外泌体 microRNA:乳腺癌的一种新型生物标志物。
Biomark Med. 2018 Feb;12(2):177-188. doi: 10.2217/bmm-2017-0305. Epub 2017 Nov 20.
6
Plasma exosome microRNAs are indicative of breast cancer.血浆外泌体微小RNA可作为乳腺癌的指示物。
Breast Cancer Res. 2016 Sep 8;18(1):90. doi: 10.1186/s13058-016-0753-x.
7
The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].外泌体在癌症进展中的多效性作用:诊断和治疗意义 [更正]。
Cell Oncol (Dordr). 2018 Jun;41(3):223-252. doi: 10.1007/s13402-018-0378-4. Epub 2018 Apr 17.
8
Exosomes in tumor microenvironment: novel transporters and biomarkers.肿瘤微环境中的外泌体:新型转运体与生物标志物
J Transl Med. 2016 Oct 19;14(1):297. doi: 10.1186/s12967-016-1056-9.
9
Exosomes released from breast cancer carcinomas stimulate cell movement.乳腺癌细胞释放的外泌体刺激细胞运动。
PLoS One. 2015 Mar 23;10(3):e0117495. doi: 10.1371/journal.pone.0117495. eCollection 2015.
10
Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).抗血管生成剂二十二碳六烯酸(DHA)可改变乳腺癌细胞中通过外泌体介导的微小RNA信号传导。
Mol Cancer. 2015 Jul 16;14:133. doi: 10.1186/s12943-015-0400-7.

引用本文的文献

1
Exosome- transported FER inhibitor suppresses progression of diffuse large B-cell lymphoma via regulating AJUBA/Hippo axis.外泌体转运的FER抑制剂通过调节AJUBA/河马轴抑制弥漫性大B细胞淋巴瘤的进展。
NPJ Precis Oncol. 2025 Jul 25;9(1):258. doi: 10.1038/s41698-025-01049-7.
2
Plasma-derived exosomal human epidermal growth factor receptor 2 (HER2) protein for distinguishing breast cancer from benign breast disease and assessing the efficacy of neoadjuvant therapy.血浆来源的外泌体人表皮生长因子受体2(HER2)蛋白用于区分乳腺癌与乳腺良性疾病及评估新辅助治疗疗效
Transl Cancer Res. 2025 May 30;14(5):3186-3200. doi: 10.21037/tcr-2025-825. Epub 2025 May 27.
3

本文引用的文献

1
Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers.乳腺癌分泌的miR-939下调血管内皮钙黏蛋白并破坏内皮单层的屏障功能。
Cancer Lett. 2017 Jan 1;384:94-100. doi: 10.1016/j.canlet.2016.09.013. Epub 2016 Sep 28.
2
Plasma exosome microRNAs are indicative of breast cancer.血浆外泌体微小RNA可作为乳腺癌的指示物。
Breast Cancer Res. 2016 Sep 8;18(1):90. doi: 10.1186/s13058-016-0753-x.
3
Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models.
The impact of liquid biopsy in breast cancer: Redefining the landscape of non-invasive precision oncology.
液体活检在乳腺癌中的影响:重新定义非侵入性精准肿瘤学格局。
J Liq Biopsy. 2025 May 21;8:100299. doi: 10.1016/j.jlb.2025.100299. eCollection 2025 Jun.
4
Characterization and Specific Detection of -Derived Extracellular Vesicles Using Anti-p40-Modified Au Thin Film.使用抗p40修饰的金薄膜对源自 的细胞外囊泡进行表征和特异性检测。 (注:原文中“-Derived”处有信息缺失)
Pharmaceutics. 2025 May 16;17(5):654. doi: 10.3390/pharmaceutics17050654.
5
Exosomes derived from M2 macrophage promote HUVECs proliferation, migration and tube formation in vitro.源自M2巨噬细胞的外泌体在体外促进人脐静脉内皮细胞的增殖、迁移和管腔形成。
Sci Rep. 2025 May 22;15(1):17876. doi: 10.1038/s41598-025-03113-5.
6
Exosome-Mediated Cellular Communication in the Tumor Microenvironment Imparts Drug Resistance in Breast Cancer.外泌体介导的肿瘤微环境中的细胞通讯赋予乳腺癌耐药性。
Cancers (Basel). 2025 Mar 30;17(7):1167. doi: 10.3390/cancers17071167.
7
Exosomes derived from natural killer cells: transforming immunotherapy for aggressive breast cancer.自然杀伤细胞衍生的外泌体:改变侵袭性乳腺癌的免疫疗法。
Med Oncol. 2025 Mar 18;42(4):114. doi: 10.1007/s12032-025-02647-y.
8
Doxorubicin loaded exosomes inhibit cancer-associated fibroblasts growth: in vitro and in vivo study.载有阿霉素的外泌体抑制癌症相关成纤维细胞生长:体外和体内研究
Cancer Cell Int. 2025 Feb 27;25(1):72. doi: 10.1186/s12935-025-03689-y.
9
Epigenetic Mechanisms in CRSwNP: The Role of MicroRNAs as Potential Biomarkers and Therapeutic Targets.慢性鼻-鼻窦炎伴鼻息肉中的表观遗传机制:微小RNA作为潜在生物标志物和治疗靶点的作用
Curr Issues Mol Biol. 2025 Feb 10;47(2):114. doi: 10.3390/cimb47020114.
10
Enhanced exosome secretion regulated by microglial P2X7R in the medullary dorsal horn contributes to pulpitis-induced pain.髓质背角中由小胶质细胞P2X7R调节的外泌体分泌增强促成了牙髓炎诱导的疼痛。
Cell Biosci. 2025 Feb 22;15(1):28. doi: 10.1186/s13578-025-01363-4.
外泌体提高阿霉素在乳腺癌和卵巢癌小鼠模型中的治疗指数。
Nanomedicine (Lond). 2016 Sep;11(18):2431-41. doi: 10.2217/nnm-2016-0154. Epub 2016 Aug 25.
4
Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.外泌体介导的miR-9递送诱导人乳腺成纤维细胞产生癌症相关的成纤维细胞样特性。
Cell Death Dis. 2016 Jul 28;7(7):e2312. doi: 10.1038/cddis.2016.224.
5
Biogenesis and Functions of Exosomes and Extracellular Vesicles.外泌体与细胞外囊泡的生物发生及功能
Methods Mol Biol. 2016;1448:201-16. doi: 10.1007/978-1-4939-3753-0_15.
6
Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer.外泌体包裹的微小RNA作为乳腺癌的循环生物标志物
Int J Cancer. 2016 Oct 1;139(7):1443-8. doi: 10.1002/ijc.30179. Epub 2016 May 31.
7
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
8
Organotropic metastasis: role of tumor exosomes.器官特异性转移:肿瘤外泌体的作用
Cell Res. 2016 Feb;26(2):149-50. doi: 10.1038/cr.2015.153. Epub 2015 Dec 25.
9
Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs.外泌体通过传递微小RNA降低乳腺癌细胞对阿霉素的敏感性。
Tumour Biol. 2016 Apr;37(4):5247-56. doi: 10.1007/s13277-015-4402-2. Epub 2015 Nov 10.
10
Tumour exosome integrins determine organotropic metastasis.肿瘤外泌体整合素决定器官特异性转移。
Nature. 2015 Nov 19;527(7578):329-35. doi: 10.1038/nature15756. Epub 2015 Oct 28.